Salt-sensitive Hypertension Study in Lantian County (SHSL)
2017年2月23日 更新者：First Affiliated Hospital Xi'an Jiaotong University
Genetics Study of Salt-Sensitive Hypertension in a Chinese Population
Essential hypertension is a complex trait which results from interaction between environmental factors and genetic factors.
Our study aimed to detect the differential expression of LncRNAs and epigenetic changes such as DNA methylation associated with salt sensitive hypertension in human based on a chronic salt loading study conducted in Lantian county, China.
Firstly, a chronic salt loading study will be conducted in a Chinese population to differentiate salt-sensitive and salt-resistant individuals.
Second, LncRNAs and DNA methylation Chip analysis will be performed using samples collected from salt-sensitive and salt resistant individual, and the results will be analyzed by modern bioinformatics methods to seek for differential genetic markers.
In addition, the investigators also try to examine the effects of chronic salt loading on BP, ambulatory BP, microalbuminuria and baPWV and other biochemical indexes.
This project had great significance to reveal molecular genetics mechanism in the development of salt, salt-sensitive and hypertension.
調査の概要
詳細な説明
The main contents include: (1) Questionnaire design: questionnaire is designed according to the research contents and purposes.
The standard questionnaires will be used to collect the general information, dietary habits, lifestyle, medical history and family history etc.(2)Anthropometric measurements: blood pressure, height, body weight, waist and hip, pulse will be acquired by medical practitioners who received professional trainings based on World Health Organization (WHO) standards, and passed relevant examinations.(3)
Dietary intervention: The dietary intervention comprise a 3-day baseline observation period, a low-salt diet for 7 days (3g of salt or 51.3mmol of sodium per day) and a high-salt diet for 7 days (18g of salt or 307.8mmol of sodium per day).
During the baseline period, each subject is given detailed dietary instructions to avoid table salt, cooking salt, and high-salt foods for the 21-day study duration.
To ensure compliance of study participants with the intervention program, they are required to have their breakfast, lunch, and dinner at the study kitchen under supervision of the study staff during the entire study period.
All foods are cooked without salt.
Onsite study staff members add prepackaged salt to the meals of individual subjects as indicated by the study protocol.
(4) Blood and urine samples collection: morning fasting blood, nocturnal enuresis, and 24-hour urine specimen will be collected by medical staffs, and blind tubes will be set up according to 5% of the total samples.
Blood biochemistries including serum total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, fasting glucose, creatinine and hsCRP can be measured using automatic biochemical analyzer.
The sodium and potassium concentrations in the urine will be measured by flame photometry.
The total sodium and potassium excretions in urine in 24h were calculated by multiplying the concentration and 24-h volume of urine.
(5) DNA methylation and LncRNA detection: Using a method of modifying a hydrogen sulfite salt and gene chip technology to detect DNA methylation and LncRNA.
(6) LncRNA: LncRNA will be measured with gene chip technology after the high salt intervention period.
(7) Auxiliary examinations: Auxiliary examinations including carotid intima-media thickness, endothelium-dependent vasodilation (FMD), measurements of brachial-ankle pulse wave velocity (baPWV) and electrocardiographic parameters.
The measurement will be done in hospitals by medical practitioners who received professional trainings and passed relevant examinations.
(8) Data processing and statistics: the investigators should input the data to the database, and utilize software such as SPSS, STATA, Haploview and FBAT to analyze.
(9)Quality control: ① Questionnaire is strictly designed and amended by epidemiologist and clinical experts.
② A standardized "Investigator Handbook" will be stipulated according to the guidelines.
③ Staff members are required to do a rigorous training and pass the exam.
④ The investigation process will be strictly supervised by the principal investigator.
⑤ Data entry use the parallel double entry method.
⑥ During laboratory testing, blank control and blind detection are applied to ensure the quality.
⑦Data analysis is performed by 2-3 postgraduates, inconsistent data need to be double checked.
研究の種類
観察的
入学 (予想される)
70
連絡先と場所
このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。
参加基準
研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。
適格基準
就学可能な年齢
18年～65年 (大人、高齢者)
健康ボランティアの受け入れ
はい
受講資格のある性別
全て
サンプリング方法
確率サンプル
調査対象母集団
The study population is ready to recruit from Shaanxi Lantian County, aged 18-65 years old and sex is not limited.
The exclusion criteria were hypertension, use of antihypertensive medication, clinical cardiovascular disease, chronic liver disease, chronic kidney disease, or diabetes mellitus, pregnancy, or high alcohol consumption.
説明
Inclusion Criteria:
- Han individuals in rural northern China
- adults aged 18-65 years
- individuals who had a mean systolic BP (SBP) between 130-160 mmHg and/or a diastolic BP (DBP) between 85-100 mmHg and no use of antihypertensive medications were identified as the proband
- the probands'parents,siblings, spouses, and offspring were recruited for the study.
Exclusion Criteria:
- Secondary hypertension
- a history of severe cardiovascular disease
- chronic kidney disease or liver disease
- unable to complete the examination
- unable/refuse to sign the informed consent form
研究計画
このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。
研究はどのように設計されていますか？
デザインの詳細
コホートと介入
グループ/コホート |
介入・治療 |
|---|---|
|
Baseline survey period
All subjects will continue a normal diet for 3 days in which questionnaire design and anthropometric measurements will be implemented.
|
|
|
Low-salt diet
All subjects will be instructed to maintain a low-salt diet for 7 days (3g of salt or 51.3mmol of sodium per day).
|
The protocol comprise a questionnaire survey and physical examination during a 3-day baseline observation period, a low-salt diet for 7 days (3g of salt per day) and a high-salt diet for 7 days (18g of salt per day).
During the baseline period, each subject is given detailed dietary instructions to avoid table salt, cooking salt, and high-salt foods for the 17-day study duration.
To ensure compliance of study participants with the intervention program, they are required to have their breakfast, lunch, and dinner at the study kitchen under supervision of the study staff during the entire study period.
All foods are cooked without salt.
Onsite study staff members add repackaged salt to the meals of individual subjects as indicated by the study protocol.
他の名前：
|
|
High -salt diet
After washout period, all subjects will be instructed to maintain a 18g of salt or 307.8mmol of sodium per day.
|
The protocol comprise a questionnaire survey and physical examination during a 3-day baseline observation period, a low-salt diet for 7 days (3g of salt per day) and a high-salt diet for 7 days (18g of salt per day).
During the baseline period, each subject is given detailed dietary instructions to avoid table salt, cooking salt, and high-salt foods for the 17-day study duration.
To ensure compliance of study participants with the intervention program, they are required to have their breakfast, lunch, and dinner at the study kitchen under supervision of the study staff during the entire study period.
All foods are cooked without salt.
Onsite study staff members add repackaged salt to the meals of individual subjects as indicated by the study protocol.
他の名前：
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
blood pressure value(mmHg)
時間枠：The first day of the three-day baseline survey period.
|
The study will last approximately 3 months (Oct 2016 to Dec 2016).
During this period, each subject will receive a three-day baseline survey examination.
Three BPs (mmHg) measurement will be obtained using a Blood Pressure Monitor on the first day of the three-day baseline survey period.
|
The first day of the three-day baseline survey period.
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Ambulatory Blood Pressure Monitoring（mmHg）
時間枠：Second day of the three-day baseline survey period
|
The study will last approximately 3 months (Oct 2016 to Dec 2016).
During this period, each subject will receive a three-day baseline survey examination.
Ambulatory blood pressure（mmHg）will be measured with Omron Ambulatory Blood Pressure Monitor during the three-day baseline survey period
|
Second day of the three-day baseline survey period
|
|
Microalbuminuria（mg/24h）
時間枠：Second day of the three-day baseline survey period
|
The study will last approximately 3 months (Oct 2016 to Dec 2016).
During this period, each subject will receive a three-day baseline survey examination.
On the second day, 24-hour urinary will be collected and the concentrations of microalbuminuria in the urine sample will be measured with Hitachi biochemical analyzer.
The 24-h microalbuminuria（mg/24h）of each subject is calculated as the concentration of microalbuminuria multiplied by the 24-h urine volume of each individual.
|
Second day of the three-day baseline survey period
|
|
Increased arterial stiffness（baPWV,mm/s）
時間枠：Second day of the three-day baseline survey period
|
The study will last approximately 3 months (Oct 2016 to Dec 2016).
During this period, each subject will receive a three-day baseline survey examination.
Brachial-ankle pulse wave velocity（baPWV, mm/s）will be measured with Noninvasive automatic waveform analyzer during the three-day baseline survey period.
|
Second day of the three-day baseline survey period
|
|
DNA methylation
時間枠：Last day of the low salt or high salt intervention period
|
The study will last approximately 3 months (Oct 2016 to Dec 2016).
During this period, each subject will receive a seven-day high salt intervention subsequent to a seven-day low salt intervention.
DNA methylation will be measured with a method of modifying a hydrogen sulfite salt at the last day of the low salt or high salt intervention.
|
Last day of the low salt or high salt intervention period
|
|
LncRNA
時間枠：Last day of the low salt or high salt intervention period
|
The study will last approximately 3 months (Oct 2016 to Dec 2016).
During this period, each subject will receive a seven-day high salt intervention subsequent to a seven-day low salt intervention.
IncRNA will be measured with gene chip technology at the last day of the low salt or high salt intervention.
|
Last day of the low salt or high salt intervention period
|
協力者と研究者
ここでは、この調査に関係する人々や組織を見つけることができます。
捜査官
- 主任研究者：Jianjun Mu, doctor、First Affiliated Hospital Xi'an Jiaotong University
出版物と役立つリンク
研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。
一般刊行物
- Mu J, Zheng S, Lian Q, Liu F, Liu Z. Evolution of blood pressure from adolescents to youth in salt sensitivies: a 18-year follow-up study in Hanzhong children cohort. Nutr J. 2012 Sep 14;11:70. doi: 10.1186/1475-2891-11-70.
- Liu F, Zheng S, Mu J, Chu C, Wang L, Wang Y, Xiao H, Wang D, Cao Y, Ren K, Liu E, Yuan Z. Common variation in with no-lysine kinase 1 (WNK1) and blood pressure responses to dietary sodium or potassium interventions- family-based association study. Circ J. 2013;77(1):169-74. doi: 10.1253/circj.cj-12-0900. Epub 2012 Oct 12.
- Wang Y, Liu FQ, Wang D, Mu JJ, Ren KY, Guo TS, Chu C, Wang L, Geng LK, Yuan ZY. Effect of salt intake and potassium supplementation on serum renalase levels in Chinese adults: a randomized trial. Medicine (Baltimore). 2014 Jul;93(6):e44. doi: 10.1097/MD.0000000000000044.
- Wang Y, Jia H, Gao WH, Zou T, Yao S, Du MF, Zhang XY, Chu C, Liao YY, Chen C, Wang D, Ma Q, Hu JW, Wang KK, Yan Y, Sun Y, Hu GL, Niu ZJ, Zhou HW, Zhang X, Wang X, Li CH, Chen FY, Gao K, Zhang J, Guan YJ, Chang J, Yang TL, Mu JJ. Associations of plasma PAPP-A2 and genetic variations with salt sensitivity, blood pressure changes and hypertension incidence in Chinese adults. J Hypertens. 2021 Sep 1;39(9):1817-1825. doi: 10.1097/HJH.0000000000002846.
- Zhang J, Yin Y, Chen L, Chu C, Wang Y, Lv Y, He M, Martin M, Huang PH, Mu JJ, Shyy JY, Yuan ZY. Short-Term High-Salt Diet Increases Corin Level to Regulate the Salt-Water Balance in Humans and Rodents. Am J Hypertens. 2018 Jan 12;31(2):253-260. doi: 10.1093/ajh/hpx148.
研究記録日
これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。
主要日程の研究
研究開始 (予想される)
2017年2月28日
一次修了 (予想される)
2017年3月1日
研究の完了 (予想される)
2017年3月1日
試験登録日
最初に提出
2016年9月21日
QC基準を満たした最初の提出物
2016年9月22日
最初の投稿 (見積もり)
2016年9月27日
学習記録の更新
投稿された最後の更新 (実際)
2017年2月27日
QC基準を満たした最後の更新が送信されました
2017年2月23日
最終確認日
2016年9月1日
詳しくは
本研究に関する用語
その他の研究ID番号
- NSFC(81570381)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
いいえ
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
いいえ
米国FDA規制機器製品の研究
いいえ
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。